Ohio Invokana Kidney Damage Lawyers | Columbus Drug Law Firm

During these unprecedented times, Clark, Perdue, & List Co, LPA is here to fully support your needs in a timely and safe manner. COVID-19 should not affect your ability to investigate a personal injury case. We currently remain open and are still accepting new cases. With your safety top of mind, we are scheduling all meetings via telephone or video conference at this time.

Invokana Kidney Damage

Ohio Invokana Kidney Damage Lawyers

There is growing concern that a popular medication prescribed for Type II diabetes may cause ketoacidosis and kidney damages. If you or a loved one has suffered injury as a result of the use of Invokana, our legal team may be able to help.

On December 4, 2015, the U.S. Food and Drug Administration (“FDA”) issued a safety announcement concerning a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (“SGLT2”) inhibitors. The announcement warned of the risks of too much acid in the blood and of serious urinary tract infections, both of which can result in serious injuries and hospitalization.

Invokana (canagliflozin) is a SGLT2 class drug that is designed to control blood sugar levels in people diagnosed with type 2 diabetes. It works by helping the kidneys removed excess sugar from the body through urination.

What is the problem with Invokana?

According to the FDA, dozens of people have been hospitalized for ketoacidosis after ingesting SGLT2 class drugs. Ketoacidosis is serious condition in which the body produces high levels of blood acids called ketones. Symptoms of ketoacidosis include abdominal pain, breathing difficulties, nausea, vomiting, and tiredness.

 

How can I get more information?

Clark, Perdue & List is currently investigating cases involving ketoacidosis. If you or loved one has taken Invokana and suffered these serious symptoms, please call or contact us by email.

RECENT BLOG POSTS FOR DANGEROUS DRUGS

Vaping Increases Severity of COVID-19 Symptoms

The link between COVID-19 and vaping is becoming more apparent as new research emerges. Evidence shows that the virus may have an easier time infecting the lungs of smokers and vapers.  According to a recent article in the New York Times, smoking appears to alter the...

read more

E-Cigarette Companies Asking for An Extension from the FDA

Due to the recent coronavirus pandemic, e-cigarette makers are looking for an extension on their Food & Drug Administration (FDA) applications. A deadline of May 12, 2020 was previously set as a result of a lawsuit filed by the American Academy of Pediatrics.  The...

read more

FDA Proposes Recall of Zantac

The Food and Drug Administration has requested drug manufacturers recall the popular heart burn medication, Zantac. This move comes as a continuing FDA investigation has found that Zantac, and other drugs with the active ingredient ranitidine, often contain...

read more

Vaping and Smoking May Increase Your COVID-19 Risks

As the entire world struggles with the new realities of the coronavirus pandemic, much of the focus has been on higher-risk individuals contracting the virus.  Higher risk individuals include the elderly and people with compromised immune systems.  There is now...

read more

Vaping Deaths and Lung Injuries Continue to Rise

Deaths and Lung Injuries Continue to Rise From E-Cigarette and Vaping Use As of February 18, 2020, 68 deaths have been confirmed in 29 states due to the use of vaping products. Additionally, a total of 2,807 hospitalized e-cigarette, or vaping, product use-associated...

read more